BioNTech SE - Limited Power of Attorney for SEC Reporting Obligations

This filing concerns a Limited Power of Attorney granted by Dr. Susanne Schaffert, a director of BioNTech SE, to Zoey Neuenschwander, Stefanie Lutze, and Humza Bokhari. The attorneys-in-fact are authorized to submit SEC filings, including Form ID, Passphrase Update Applications, and Section 16 filings (Forms 144, Schedules 13D, and 13G) on behalf of Dr. Schaffert. They are empowered to take any necessary actions for these filings, including executing amendments and delivering them to the SEC and other relevant authorities. The attorneys-in-fact are also authorized to obtain information about transactions in BioNTech SE securities from third parties. This power of attorney remains in effect until Dr. Schaffert is no longer required to file such documents or until it is revoked in writing. The document is dated May 15, 2026.